CRNX CRINETICS PHARMACEUTICALS INC Product Launches 8-K Filing 2024 - New Drug Application Crinetics Pharmaceuticals submitted a New Drug Application to the FDA for paltusotine, a new treatment for acromegaly, marking a significant step in its development.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC